Capmatinib (INC280): Selectivity & Specificity
Capmatinib (INC280) is a potent inhibitor of c-Met kinase (0.13 nM), MET (0.13 nM), P-gp (12.0 μM), and BCRP (16.4 μM). Capmatinib (INC280) exhibits the greatest inhibitory potency toward MET (IC50 = 0.13 nM).
Jump to
- Capmatinib (INC280) Mechanism of Action: MET Inhibition in Non-Small Cell Lung Cancer Cells Research
- Capmatinib (INC280) Clinical Trials
- Capmatinib (INC280) Working Concentration | Cell Culture | Treatment
- Capmatinib (INC280) Solubility in DMSO
- Capmatinib (INC280) Stock Solution
- Capmatinib (INC280) Storage
- Capmatinib (INC280) Stability
- Capmatinib (INC280) Combination Database
- Capmatinib (INC280) Molecular Weight
- Capmatinib (INC280) SMILES
- Capmatinib (INC280) CAS Number
- Capmatinib (INC280) Chemical Structure (2D and 3D)
- Capmatinib (INC280) IC50 for Cell-based and Cell-free Assays
- Capmatinib (INC280) MedChemExpress (HY-13404)? Try a better option.
- Capmatinib (INC280) Cayman (20056)? Try a better option.
- Capmatinib (INC280) APExBIO (A8448)? Try a better option.
- Capmatinib (INC280) SDS｜MSDS